Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
- PMID: 38543009
- PMCID: PMC10976257
- DOI: 10.3390/molecules29061373
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
Abstract
Epigallocatechin gallate (EGCG) is a catechin, which is a type of flavonoid found in high concentrations in green tea. EGCG has been studied extensively for its potential health benefits, particularly in cancer. EGCG has been found to exhibit anti-proliferative, anti-angiogenic, and pro-apoptotic effects in numerous cancer cell lines and animal models. EGCG has demonstrated the ability to interrupt various signaling pathways associated with cellular proliferation and division in different cancer types. EGCG anticancer activity is mediated by interfering with various cancer hallmarks. This article summarize and highlight the effects of EGCG on cancer hallmarks and focused on the impacts of EGCG on these cancer-related hallmarks. The studies discussed in this review enrich the understanding of EGCG's potential as a therapeutic tool against cancer, offering a substantial foundation for scientists and medical experts to advance scientific and clinical investigations regarding EGCG's possibility as a potential anticancer treatment.
Keywords: angiogenesis; anticancer; cancer hallmarks; epigallocatechin gallate (EGCG); immune evasion; metastasis.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10976257/bin/molecules-29-01373-g002.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10976257/bin/molecules-29-01373-g001.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10976257/bin/molecules-29-01373-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10976257/bin/molecules-29-01373-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10976257/bin/molecules-29-01373-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10976257/bin/molecules-29-01373-g006.gif)
Similar articles
-
Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.Molecules. 2020 Jul 9;25(14):3146. doi: 10.3390/molecules25143146. Molecules. 2020. PMID: 32660101 Free PMC article. Review.
-
Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.Semin Cancer Biol. 2022 May;80:256-275. doi: 10.1016/j.semcancer.2020.05.011. Epub 2020 May 24. Semin Cancer Biol. 2022. PMID: 32461153 Review.
-
From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer.Nutr Res. 2020 Feb;74:23-36. doi: 10.1016/j.nutres.2019.12.004. Epub 2019 Dec 10. Nutr Res. 2020. PMID: 31918176 Review.
-
In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-O-gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea.Molecules. 2018 May 28;23(6):1295. doi: 10.3390/molecules23061295. Molecules. 2018. PMID: 29843451 Free PMC article. Review.
-
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.Mol Aspects Med. 2012 Feb;33(1):107-18. doi: 10.1016/j.mam.2011.10.001. Epub 2011 Oct 14. Mol Aspects Med. 2012. PMID: 22020144 Review.
References
-
- Almatroodi S.A., Almatroudi A., Khan A.A., Alhumaydhi F.A., Alsahli M.A., Rahmani A.H. Potential therapeutic targets of epigallocatechin gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer. Molecules. 2020;25:3146. doi: 10.3390/molecules25143146. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources